Published Paper eCOA Systems and Intended Use: Key Considerations Sign Up Sign Up Science 37 VP of Global Product Development, Lisa Charlton, and other experts from the Critical Path Institute Consortium provided important considerations when interpreting data collected through Clinical Outcome Assessments (COAs). Fill out form to register
